The potential involvement of growth hormone therapy in tumor promotion and progression has been of concern for several decades. Our aim was to assess systematically the association between growth hormone therapy and all-cause, cancer and cardiovascular mortality, cancer morbidity and risk of second neoplasm mainly in patients treated during childhood and adolescence.
Deodati, A., Ferroli, B., Cianfarani, S. (2014). Association between growth hormone therapy and mortality, cancer and cardiovascular risk: systematic review and meta-analysis. GROWTH HORMONE & IGF RESEARCH, 24(4), 105-111 [10.1016/j.ghir.2014.02.001].
Association between growth hormone therapy and mortality, cancer and cardiovascular risk: systematic review and meta-analysis
Deodati, A;Cianfarani, S
2014-08-01
Abstract
The potential involvement of growth hormone therapy in tumor promotion and progression has been of concern for several decades. Our aim was to assess systematically the association between growth hormone therapy and all-cause, cancer and cardiovascular mortality, cancer morbidity and risk of second neoplasm mainly in patients treated during childhood and adolescence.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
